Arnt V. Kristen
Arnt V. Kristen
Senior physician, Department of Cardiology, University of Heidelberg; Kardiovaskuläres Zentrum
Verified email at - Homepage
Cited by
Cited by
Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis
D Adams, A Gonzalez-Duarte, WD O’Riordan, CC Yang, M Ueda, ...
New England Journal of Medicine 379 (1), 11-21, 2018
Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy
MS Maurer, JH Schwartz, B Gundapaneni, PM Elliott, G Merlini, ...
New England Journal of Medicine 379 (11), 1007-1016, 2018
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of …
S Dorbala, Y Ando, S Bokhari, A Dispenzieri, RH Falk, VA Ferrari, ...
Journal of Nuclear Cardiology 26 (6), 2065-2123, 2019
Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)
MS Maurer, M Hanna, M Grogan, A Dispenzieri, R Witteles, B Drachman, ...
Journal of the American College of Cardiology 68 (2), 161-172, 2016
Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers
SJ Buss, M Emami, D Mereles, G Korosoglou, AV Kristen, A Voss, ...
Journal of the American College of Cardiology 60 (12), 1067-1076, 2012
Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis: analysis of the APOLLO study
SD Solomon, D Adams, A Kristen, M Grogan, A González-Duarte, ...
Circulation 139 (4), 431-443, 2019
Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis
MS Maurer, S Bokhari, T Damy, S Dorbala, BM Drachman, M Fontana, ...
Circulation: Heart Failure 12 (9), e006075, 2019
Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death
AV Kristen, TJ Dengler, U Hegenbart, SO Schonland, H Goldschmidt, ...
Heart rhythm 5 (2), 235-240, 2008
Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension
FJ Meyer, D Lossnitzer, AV Kristen, AM Schoene, W Kübler, HA Katus, ...
European Respiratory Journal 25 (1), 125-130, 2005
Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis
AV Kristen, S Ajroud-Driss, I Conceição, P Gorevic, T Kyriakides, L Obici
Neurodegenerative disease management 9 (1), 5-23, 2019
Green tea halts progression of cardiac transthyretin amyloidosis: an observational report
AV Kristen, S Lehrke, S Buss, D Mereles, H Steen, P Ehlermann, S Hardt, ...
Clinical Research in Cardiology 101 (10), 805-813, 2012
Non‐invasive predictors of survival in cardiac amyloidosis
AV Kristen, JB Perz, SO Schonland, U Hegenbart, PA Schnabel, ...
European journal of heart failure 9 (6-7), 617-624, 2007
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
P Garcia-Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ...
European heart journal 42 (16), 1554-1568, 2021
Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe …
S Dietrich, SO Schönland, A Benner, T Bochtler, AV Kristen, J Beimler, ...
Blood, The Journal of the American Society of Hematology 116 (4), 522-528, 2010
Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay
AV Kristen, E Giannitsis, S Lehrke, U Hegenbart, M Konstandin, ...
Blood, The Journal of the American Society of Hematology 116 (14), 2455-2461, 2010
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography
J Kollmer, E Hund, B Hornung, U Hegenbart, SO Schönland, C Kimmich, ...
Brain 138 (3), 549-562, 2015
High‐dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective …
JB Perz, SO Schonland, M Hundemer, AV Kristen, TJ Dengler, M Zeier, ...
British journal of haematology 127 (5), 543-551, 2004
Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
T Damy, AV Kristen, OB Suhr, MS Maurer, V Plante-Bordeneuve, CR Yu, ...
European heart journal 43 (5), 391-400, 2022
Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and …
FU Sack, A Kristen, H Goldschmidt, PA Schnabel, T Dengler, A Koch, ...
European journal of cardio-thoracic surgery 33 (2), 257-262, 2008
Cardiac amyloid load: a prognostic and predictive biomarker in patients with light-chain amyloidosis
AV Kristen, E Brokbals, F aus dem Siepen, R Bauer, S Hein, M Aurich, ...
Journal of the American College of Cardiology 68 (1), 13-24, 2016
The system can't perform the operation now. Try again later.
Articles 1–20